Cited by 734Telomeres, Telomerase, and SenescenceImmunotherapy and Immune ResponsesVirus-based gene therapy research

The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.

Telomerase and cancer therapeutics

Harley, Calvin B.·2008·Nature Reviews Cancer

Open this paper in CoChat — free account

Abstract

Telomerase is an attractive cancer target as it appears to be required in essentially all tumours for immortalization of a subset of cells, including cancer stem cells. Moreover, differences in telomerase expression, telomere length and cell kinetics between normal and tumour tissues suggest that targeting telomerase would be relatively safe. Clinical trials are ongoing with a potent and specific telomerase inhibitor, GRN163L, and with several versions of telomerase therapeutic vaccines. The prospect of adding telomerase-based therapies to the growing list of new anticancer products is promising, but what are the advantages and limitations of different approaches, and which patients are the most likely to respond?

Integrity signals

Registry

Crossref · 10.1038/nrc2275

Cites

147 of 147 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Effects of oligonucleotide N3'-->P5' thio-phosphoramidate (GRN163) targeting telomerase RNA in human multiple myeloma cells.
Akiyama, M., Hideshima, T., Shammas, M. A., Hayashi, T., Hamasaki, M., Tai, Y., Richardson, P. G. G., Gryaznov, S. M., Munshi, N. C., & Anderson, K. C. (2003) · PubMed · Cited by 84
Retracted
The hallmarks of cancer
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Self-citation
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Self-citation
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400
Shelterin: the protein complex that shapes and safeguards human telomeres
de Lange, T. (2005) · Genes & Development · doi:10.1101/gad.1346005 · Cited by 3,056
Accelerated telomere shortening in response to life stress
Epel, E. S., Blackburn, E. H., Lin, J., Dhabhar, F. S., Adler, N. E., Morrow, J. D., & Cawthon, R. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407162101 · Cited by 3,002
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
A survey of telomerase activity in human cancer
Shay, J. W., & Bacchetti, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00062-2 · Cited by 2,794
The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype
Zhou, S., Schuetz, J. D., Bunting, K. D., Colapietro, A.-M., Sampath, J., Morris, J. J., Lagutina, I., Grosveld, G. C., Osawa, M., Nakauchi, H., et al. (2001) · Nature Medicine · doi:10.1038/nm0901-1028 · Cited by 2,280
Telomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256
Self-citation
The RNA Component of Human Telomerase
Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. (1995) · Science · doi:10.1126/science.7544491 · Cited by 2,227
Self-citation
Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity.
Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096
Self-citation
hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization
Meyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80538-3 · Cited by 1,784
Association between telomere length in blood and mortality in people aged 60 years or older
Cawthon, R. M., Smith, K. R., O'Brien, E., Sivatchenko, A., & Kerber, R. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12384-7 · Cited by 1,761
Telomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650
A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis
Greider, C. W., & Blackburn, E. H. (1989) · Nature · doi:10.1038/337331a0 · Cited by 1,643
Telomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357
The Shortest Telomere, Not Average Telomere Length, Is Critical for Cell Viability and Chromosome Stability
Hemann, M. T., Strong, M. A., Hao, L.-Y., & Greider, C. W. (2001) · Cell · doi:10.1016/s0092-8674(01)00504-9 · Cited by 1,219
Control of telomere length by the human telomeric protein TRF1
van Steensel, B., & de Lange, T. (1997) · Nature · doi:10.1038/385740a0 · Cited by 1,219
Telomere loss: mitotic clock or genetic time bomb?
Harley, C. B. (1991) · Mutation Research/DNAging · doi:10.1016/0921-8734(91)90018-7 · Cited by 1,139
Self-citation
Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age.
Vaziri, H., Dragowska, W., Allsopp, R. C., Thomas, T. E., Harley, C. B., & Lansdorp, P. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9857 · Cited by 1,132
Self-citation
Telomere end-replication problem and cell aging
Levy, M. Z., Allsopp, R. C., Futcher, A. B., Greider, C. W., & Harley, C. B. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90096-3 · Cited by 1,069
Self-citation
Inhibition of telomerase limits the growth of human cancer cells
Hahn, W. C., Stewart, S. A., Brooks, M. W., York, S. G., Eaton, E. N., Kurachi, A. L., Beijersbergen, R. L., Knoll, J. H. M., Meyerson, M. M., & Weinberg, R. A. (1999) · Nature Medicine · doi:10.1038/13495 · Cited by 1,038
The common biology of cancer and ageing
Finkel, T., Serrano, M., & Blasco, M. A. (2007) · Nature · doi:10.1038/nature05985 · Cited by 988
Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT
Weinrich, S. L., Pruzan, R., Ma, L., Ouellette, M. M., Tesmer, V. M., Holt, S. E., Bodnar, A. G., Lichtsteiner, S., Kim, N. W., Trager, J. B., et al. (1997) · Nature Genetics · doi:10.1038/ng1297-498 · Cited by 975
Self-citation
Side Population in Human Lung Cancer Cell Lines and Tumors Is Enriched with Stem-like Cancer Cells
Ho, M., Ng, A. V., Lam, S. C., & Hung, J. Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3557 · Cited by 952
Human telomere, oncogenic promoter and 5'-UTR G-quadruplexes: diverse higher order DNA and RNA targets for cancer therapeutics
Patel, D. J., Phan, A. T., & Kuryavyi, V. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm711 · Cited by 892
Senescence Induced by Altered Telomere State, Not Telomere Loss
Karlseder, J., Smogorzewska, A., & de Lange, T. (2002) · Science · doi:10.1126/science.1069523 · Cited by 796
Leukocyte Telomere Length and Cardiovascular Disease in the Cardiovascular Health Study
Fitzpatrick, A. L., Kronmal, R. A., Gardner, J. P., Psaty, B. M., Jenny, N. S., Tracy, R. P., Walston, J., Kimura, M., & Aviv, A. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj346 · Cited by 773
Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting
Tacken, P. J., de Vries, I. J. M., Torensma, R., & Figdor, C. G. (2007) · Nature reviews. Immunology · doi:10.1038/nri2173 · Cited by 761
Telomerase activity in normal and malignant hematopoietic cells.
Broccoli, D., Young, J. W., & de Lange, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9082 · Cited by 754
Telomere length, stem cells and aging
Blasco, M. A. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.38 · Cited by 747
Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study
Brouilette, S., Moore, J. S., McMahon, A. D., Thompson, J. R., Ford, I., Shepherd, J., Packard, C. J., & Samani, N. J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60071-3 · Cited by 747
Telomerase activity in human ovarian carcinoma.
Counter, C. M., Hirte, H. W., Bacchetti, S., & Harley, C. B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.2900 · Cited by 677
Self-citation
Protein Composition of Catalytically Active Human Telomerase from Immortal Cells
Cohen, S. B., Graham, M. E., Lovrecz, G. O., Bache, N., Robinson, P. J., & Reddel, R. R. (2007) · Science · doi:10.1126/science.1138596 · Cited by 669
Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas
Nakayama, J., Tahara, H., 栄治, 田., Saito, M., Ito, K., Nakamura, H., Nakanishi, T., Nakanishi, E., Ide, T., & Ishikawa, F. (1998) · Nature Genetics · doi:10.1038/ng0198-65 · Cited by 605
Isolation of a Candidate Human Telomerase Catalytic Subunit Gene, Which Reveals Complex Splicing Patterns in Different Cell Types
Kilian, A., Bowtell, D. D. L., Abud, H. E., Hime, G. R., Venter, D. J., Keese, P., Duncan, E. L., Reddel, R. R., & Jefferson, R. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.12.2011 · Cited by 592
Telomere Length Homeostasis Is Achieved via a Switch between Telomerase- Extendible and -Nonextendible States
Teixeira, M. T., Arneric, M., Sperisen, P., & Lingner, J. (2004) · Cell · doi:10.1016/s0092-8674(04)00334-4 · Cited by 526
A Box H/ACA Small Nucleolar RNA-Like Domain at the Human Telomerase RNA 3′ End
Mitchell, J. R., Cheng, J., & Collins, K. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.567 · Cited by 510
Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study
Demissie, S., Levy, D., Benjamin, E. J., Cupples, L. A., Gardner, J. P., Herbert, A., Kimura, M., Larson, M. G., Meigs, J. B., Keaney, J. F., et al. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00224.x · Cited by 508
Telomere Length in the Newborn
Okuda, K., Bardeguez, A., Gardner, J. P., Rodriguez, P., Ganesh, V., Kimura, M., Skurnick, J., Awad, G., & Aviv, A. (2002) · Pediatric Research · doi:10.1203/00006450-200209000-00012 · Cited by 507
Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts.
Ulaner, G. A., Hu, J., Vu, T. H., Giudice, L. C., & Hoffman, A. R. (1998) · PubMed · Cited by 495
Human telomerase contains evolutionarily conserved catalytic and structural subunits
Harrington, L., Zhou, W., McPhail, T., Oulton, R., Yeung, D. S. K., Mar, V., Bass, M. B., & Robinson, M. O. (1997) · Genes & Development · doi:10.1101/gad.11.23.3109 · Cited by 465
Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC
Vulliamy, T., Marrone, A., Szydlo, R., Walne, A., Mason, P. J., & Dokal, I. (2004) · Nature Genetics · doi:10.1038/ng1346 · Cited by 461
Flow cytometry and FISH to measure the average length of telomeres (flow FISH)
Baerlocher, G. M., Vulto, I., de Jong, G., & Lansdorp, P. M. (2006) · Nature Protocols · doi:10.1038/nprot.2006.263 · Cited by 449
Telosome, a Mammalian Telomere-associated Complex Formed by Multiple Telomeric Proteins
Liu, D., O'Connor, M. S., Qin, J., & Songyang, Z. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409293200 · Cited by 405
Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals
Goronzy, J. J., Fulbright, J. W., Crowson, C. S., Poland, G. A., O'Fallon, W. M., & Weyand, C. M. (2001) · Journal of Virology · doi:10.1128/jvi.75.24.12182-12187.2001 · Cited by 402
Telomerase, Cell Immortality, and Cancer
Harley, C. B., Kim, N. W., Prowse, K. R., Weinrich, S. L., Hirsch, K. S., West, M. D., Bacchetti, S., Hirte, H. W., Counter, C. M., Greider, C. W., et al. (1994) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1994.059.01.035 · Cited by 396
Self-citation
Differential Expression of Telomerase Activity in Hematopoietic Progenitors from Adult Human Bone Marrow
Chiu, C., Dragowska, W., Kim, N. W., Vaziri, H., Yui, J., Thomas, T. E., Harley, C. B., & Lansdorp, P. M. (1996) · STEM CELLS · doi:10.1002/stem.140239 · Cited by 388
Self-citation
Telomere length is paternally inherited and is associated with parental lifespan
Njajou, O. T., Cawthon, R. M., Damcott, C. M., Wu, S.-H., Ott, S., Garant, M. J., Blackburn, E. H., Mitchell, B. D., Shuldiner, A. R., & Hsueh, W.-C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702703104 · Cited by 387
Short Dysfunctional Telomeres Impair Tumorigenesis in the INK4aΔ2/3 Cancer-Prone Mouse
Greenberg, R. A., Chin, L., Femino, A., Lee, K.-H., Gottlieb, G. J., Singer, R. H., Greider, C. W., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80761-8 · Cited by 367
Telomerase mRNA-Transfected Dendritic Cells Stimulate Antigen-Specific CD8+ and CD4+ T Cell Responses in Patients with Metastatic Prostate Cancer
Su, Z., Dannull, J., Yang, B. K., Dahm, P., Coleman, D., Yancey, D., Sichi, S., Niedzwiecki, D., Boczkowski, D., Gilboa, E., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3798 · Cited by 359
Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.
Nair, S. K., Heiser, A., Boczkowski, D., Majumdar, A. S., Naoe, M., LEBKOWSKI, J. S., Vieweg, J., & Gilboa, E. (2000) · Nature Medicine · doi:10.1038/79519 · Cited by 348
Mechanism of Human Telomerase Inhibition by BIBR1532, a Synthetic, Non-nucleosidic Drug Candidate
Pascolo, E., Wenz, C., Lingner, J., Hauel, N. H., Priepke, H. W. M., Kauffmann, I., Garin‐Chesa, P., Rettig, W. J., Damm, K., & Schnapp, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201266200 · Cited by 336
Physiological relevance of telomeric G‐quadruplex formation: a potential drug target
Oganesian, L., & Bryan, T. M. (2007) · BioEssays · doi:10.1002/bies.20523 · Cited by 318
A G-Quadruplex-Interactive Potent Small-Molecule Inhibitor of Telomerase Exhibiting in Vitro and in Vivo Antitumor Activity
Gowan, S. M., Harrison, J. R., Patterson, L., Valenti, M. R., Read, M. A., Neidle, S., & Kèlland, L. R. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.5.1154 · Cited by 313
Short Telomeres Are Associated With Increased Carotid Atherosclerosis in Hypertensive Subjects
Benetos, A., Gardner, J. P., Zureik, M., Labat, C., Xiaobin, L., Adamopoulos, C., Temmar, M., Bean, K. E., Thomas, F., & Aviv, A. (2004) · Hypertension · doi:10.1161/01.hyp.0000113081.42868.f4 · Cited by 313
Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation
Wong, K.-K., Chang, S., Weiler, S. R., Ganesan, S., Chaudhuri, J., Zhu, C., Artandi, S. E., Rudolph, K. L., Gottlieb, G. J., Chin, L., et al. (2000) · Nature Genetics · doi:10.1038/79232 · Cited by 309
Evidence for a New Step in Telomere Maintenance
Wellinger, R. J., Ethier, K., Labrecque, P., & Zakian, V. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81120-4 · Cited by 308
Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: a dose escalating phase I/II study
Bernhardt, S. L., Gjertsen, M. K., Trachsel, S., Møller, M., Eriksen, J. A., Meo, M. L., Buanes, T. A., & Gaudernack, G. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603437 · Cited by 303
Telomere length homeostasis
Hug, N., & Lingner, J. (2006) · Chromosoma · doi:10.1007/s00412-006-0067-3 · Cited by 291
Mechanism of Telomerase Induction during T Cell Activation
Bodnar, A. G., Kim, N. W., Effros, R. B., & Chiu, C. (1996) · Experimental Cell Research · doi:10.1006/excr.1996.0299 · Cited by 285
Structure of a G-quadruplex–Ligand Complex
Haider, S. M., Parkinson, G. N., & Neidle, S. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)01354-2 · Cited by 278
Subsenescent Telomere Lengths in Fibroblasts Immortalized by Limiting Amounts of Telomerase
Ouellette, M. M., Liao, M., Herbert, B., Johnson, M. D. D., Holt, S. E., Liss, H. S., Shay, J. W., & Wright, W. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10072 · Cited by 272
In vivo Inhibition of Lung Cancer by GRN163L: A Novel Human Telomerase Inhibitor
Dikmen, Z. G., Gellert, G. C., Jackson, S., Gryaznov, S., Tressler, R., Dogan, P., Wright, W. E., & Shay, J. W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1215 · Cited by 271
Lipid modification of GRN163, an N3′ → P5′ thio-phosphoramidate oligonucleotide, enhances the potency of telomerase inhibition
Herbert, B., Gellert, G. C., Hochreiter, A. E., Pongracz, K., Wright, W. E., Zielińska, D., Chin, A. C., Harley, C. B., Shay, J. W., & Gryaznov, S. M. (2005) · Oncogene · doi:10.1038/sj.onc.1208760 · Cited by 269
Self-citation
Telomeres, telomerase and senescence
Greider, C. W. (1990) · BioEssays · doi:10.1002/bies.950120803 · Cited by 267
Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect
Salvati, E., Leonetti, C., Rizzo, A., Scarsella, M., Mottolese, M., Galati, R., Sperduti, I., Stevens, M. F. G., D’Incalci, M., Blasco, M., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32461 · Cited by 266
Vaccination of Cancer Patients Against Telomerase Induces Functional Antitumor CD8+ T Lymphocytes
Vonderheide, R. H., Domchek, S. M., Schultze, J. L., George, D. J., Hoar, K. M., Chen, D.-Y., Stephans, K. F., Masutomi, K., Loda, M. F., Xia, Z., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0620-3 · Cited by 255
Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer
Brunsvig, P. F., Aamdal, S., Klemp, M., Kvalheim, G., Markowski-Grimsrud, C. J., Sve, I., Dyrhaug, M., Trachsel, S., Møller, M., Eriksen, J. A., et al. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0145-7 · Cited by 246
A novel telomerase template antagonist (GRN163) as a potential anticancer agent.
Asai, A., Oshima, Y., Yamamoto, Y., Uochi, T., Kusaka, H., Akinaga, S., Yamashita, Y., Pongracz, K., Pruzan, R., Wunder, E., et al. (2003) · PubMed · Cited by 239
Self-citation
Paternal age is positively linked to telomere length of children
Unryn, B. M., Cook, L. S., & Riabowol, K. T. (2005) · Aging Cell · doi:10.1111/j.1474-9728.2005.00144.x · Cited by 230
Telomere length is reset during early mammalian embryogenesis
Schaetzlein, S., Lucas‐Hahn, A., Lemme, E., Kues, W. A., Dorsch, M. M., Manns, M. P., Niemann, H., & Rudolph, K. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402400101 · Cited by 225
Molecular Mechanisms of Resistance to Therapies Targeting the Epidermal Growth Factor Receptor
Camp, E. R., Summy, J. M., Bauer, T. W., Liu, W., Gallick, G. E., & Ellis, L. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.397.11.1 · Cited by 210
Telomere uncapping by the G-quadruplex ligand RHPS4 inhibits clonogenic tumour cell growth in vitro and in vivo consistent with a cancer stem cell targeting mechanism
Phatak, P., Cookson, J. C., Dai, F., Smith, V., Gartenhaus, R. B., Stevens, M. F. G., & Burger, A. M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603691 · Cited by 201
WT1 gene expression: an excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients – results from a single‐centre study
Østergaard, M., Olesen, L. H., Hasle, H., Kjeldsen, E., & Hokland, P. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04952.x · Cited by 199
Telomerase as tumor marker
Hiyama, E., & Hiyama, K. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00709-7 · Cited by 197
Telomerase is not an oncogene
Harley, C. B. (2002) · Oncogene · doi:10.1038/sj.onc.1205076 · Cited by 194
Self-citation
Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations
Damle, R. N., Batliwalla, F., Ghiotto, F., Valetto, A., Albesiano, E., Sison, C. P., Allen, S. L., Kolitz, J. E., Vinciguerra, V. P., Kudalkar, P., et al. (2003) · Blood · doi:10.1182/blood-2003-04-1345 · Cited by 190
Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progression
Chang, S., Khoo, C. M., Naylor, M. L., Maser, R. S., & DePinho, R. A. (2003) · Genes & Development · doi:10.1101/gad.1029903 · Cited by 183
Telomerase Activity Concentrates in the Mitotically Active Segments of Human Hair Follicles
Ramirez, R. D., Wright, W. E., Shay, J. W., & Taylor, R. S. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12285654 · Cited by 174
Disruption of Telomere Maintenance by Depletion of the MRE11/RAD50/NBS1 Complex in Cells That Use Alternative Lengthening of Telomeres
Zhong, Z.-H., Jiang, W.-Q., Cesare, A. J., Neumann, A. A., Wadhwa, R., & Reddel, R. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701413200 · Cited by 166
Cellular and Gene Expression Responses Involved in the Rapid Growth Inhibition of Human Cancer Cells by RNA Interference-mediated Depletion of Telomerase RNA
Li, S., Crothers, J., Haqq, C. M., & Blackburn, E. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502782200 · Cited by 160
Induction of Ovarian Cancer Cell Apoptosis by 1,25-Dihydroxyvitamin D3 through the Down-regulation of Telomerase
Jiang, F., Bao, J., Li, P., Nicosia, S. V., & Bai, W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410395200 · Cited by 153
Telomerase Antagonists GRN163 and GRN163L Inhibit Tumor Growth and Increase Chemosensitivity of Human Hepatoma *
Djojosubroto, M. W., Chin, A. C., Go, N., Schaetzlein, S., Manns, M. P., Gryaznov, S., Harley, C. B., & Rudolph, L. K. (2005) · Hepatology · doi:10.1002/hep.20822 · Cited by 151
Self-citation
[Telomerase as a tumor marker?].
Hummel, M., Heine, B., Demel, G., & Stein, H. (1997) · PubMed · Cited by 149
Developmental regulation of telomerase activity in human fetal tissues during gestation
Ulaner, G. A. (1997) · Molecular Human Reproduction · doi:10.1093/molehr/3.9.769 · Cited by 148
Telomerase Template Antagonist GRN163L Disrupts Telomere Maintenance, Tumor Growth, and Metastasis of Breast Cancer
Hochreiter, A. E., Xiao, H., Goldblatt, E. M., Gryaznov, S. M., Miller, K. D., Badve, S., Sledge, G. W., & Herbert, B.-S. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2760 · Cited by 146
Mechanism of acridine-based telomerase inhibition and telomere shortening
Gunaratnam, M., Greciano, O., Martins, C., Reszka, A. P., Schultes, C. M., Morjani, H., Riou, J., & Neidle, S. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.011 · Cited by 145
Targeting the Limitless Replicative Potential of Cancer: The Telomerase/Telomere Pathway
Kèlland, L. R. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0422 · Cited by 145
Telomerase levels control the lifespan of human T lymphocytes
Röth, A., Yssel, H., Pène, J., Chavez, E. A., Schertzer, M., Lansdorp, P. M., Spits, H., & Luiten, R. M. (2003) · Blood · doi:10.1182/blood-2002-07-2015 · Cited by 133
Effects of a novel telomerase inhibitor, GRN163L, in human breast cancer
Gellert, G. C., Dikmen, Z. G., Wright, W. E., Gryaznov, S. M., & Shay, J. W. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9043-5 · Cited by 126
Pattern abnormalities induced by ectopic expression of the Drosophila gene hairy are associated with repression of ftz transcription
Ish‐Horowicz, D., & Pinchin, S. M. (1987) · Cell · doi:10.1016/0092-8674(87)90636-2 · Cited by 124
Human Cancer Cells Harbor T-Stumps, a Distinct Class of Extremely Short Telomeres
Xu, L., & Blackburn, E. H. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.10.005 · Cited by 123
Enhanced induction of telomerase-specific CD4(+) T cells using dendritic cells transfected with RNA encoding a chimeric gene product.
Su, Z. Z., Vieweg, J., Weizer, A. Z., Dahm, P., Yancey, D. R., Turaga, V., Higgins, J., Boczkowski, D., Gilboa, E., & Dannull, J. (2002) · PubMed · Cited by 117
Immunization of Patients with the hTERT:540-548 Peptide Induces Peptide-Reactive T Lymphocytes That Do Not Recognize Tumors Endogenously Expressing Telomerase
Parkhurst, M. R., Riley, J. P., Igarashi, T., Li, Y., Robbins, P. F., & Rosenberg, S. A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0325 · Cited by 111
Vaccination of Patients With Advanced Non–Small-Cell Lung Cancer With an Optimized Cryptic Human Telomerase Reverse Transcriptase Peptide
Bolonaki, I., Kotsakis, A. P., Papadimitraki, E., Aggouraki, D., Konsolakis, G., Vagia, A., Christophyllakis, C., Nikoloudi, I., Magganas, E., Galanis, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.3465 · Cited by 108
Ex Vivo Characterization of Multiepitopic Tumor-Specific CD8 T Cells in Patients with Chronic Myeloid Leukemia: Implications for Vaccine Development and Adoptive Cellular Immunotherapy
Gannagé, M., Abel, M., Michallet, A., Delluc, S., Lambert, M., Giraudier, S., Kratzer, R., Niedermann, G., Saveanu, L., Guilhot, F., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.8210 · Cited by 106
Telomerase-Specific T-Cell Immunity in Breast Cancer: Effect of Vaccination on Tumor Immunosurveillance
Domchek, S. M., Recio, A., Mick, R., Clark, C. E., Carpenter, E. L., Fox, K. R., DeMichele, A. M., Schuchter, L. M., Leibowitz, M. S., Wexler, M. H., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2765 · Cited by 103
Telomere Biology and Cellular Aging in Nonhuman Primate Cells
Steinert, S., White, D. M., Zou, Y. S., Shay, J. W., & Wright, W. E. (2002) · Experimental Cell Research · doi:10.1006/excr.2001.5409 · Cited by 100
Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells
Saretzki, G. C., Ludwig, A., von Zglinicki, T., & Runnebaum, I. B. (2001) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700383 · Cited by 100
Pharmacological Telomerase Inhibition Can Sensitize Drug-Resistant and Drug-Sensitive Cells to Chemotherapeutic Treatment
Ward, R. J., & Autexier, C. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.011494 · Cited by 99
Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy
Engelhardt, M. M., Ozkaynak, M. F., Drullinsky, P. R., Sandoval, C., Tugal, O., Jayabose, S., & Moore, M. (1998) · Leukemia · doi:10.1038/sj.leu.2400889 · Cited by 96
Preferential maintenance of critically short telomeres in mammalian cells heterozygous for mTert
Liu, Y., Kha, H. T., Ungrin, M., Robinson, M. O., & Harrington, L. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062549199 · Cited by 94
Telomerase and its potential for therapeutic intervention
Phatak, P., & Burger, A. M. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707374 · Cited by 94
Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity
Irving, J., Wang, Z., Powell, S., O’Sullivan, C., Mok, M. T. C., Murphy, B., Cardoza, L. M., LEBKOWSKI, J. S., & Majumdar, A. S. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700666 · Cited by 87
Telomerase inhibition with an oligonucleotide telomerase template antagonist: in vitro and in vivo studies in multiple myeloma and lymphoma
Wang, E. S., Wu, K., Chin, A. C., Chen‐Kiang, S., Pongracz, K., Gryaznov, S. M., & Moore, M. A. S. (2003) · Blood · doi:10.1182/blood-2003-02-0546 · Cited by 83
Telomerase induction in T cells: A cure for aging and disease?
Effros, R. B. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.11.005 · Cited by 82
Selective ablation of human cancer cells by telomerase-specific adenoviral suicide gene therapy vectors expressing bacterial nitroreductase
Bilsland, A. E., Anderson, C. J., Fletcher‐Monaghan, A. J., McGregor, F., Evans, T. R. J., Ganly, I., Knox, R. J., Plumb, J. A., & Keith, W. N. (2003) · Oncogene · doi:10.1038/sj.onc.1206168 · Cited by 78
Equivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individuals.
Vonderheide, R. H., Schultze, J. L., Anderson, K. S., Maecker‐Kolhoff, B., Butler, M. O., Xia, Z., Kuroda, M. J., von Bergwelt‐Baildon, M. S., Bedor, M., Hoar, K. M., et al. (2001) · PubMed · Cited by 77
Telomerase and Cancer Stem CellsPreprint
Armanios, M. Y., & Greider, C. W. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.030 · Cited by 76
Specific telomere dysfunction induced by GRN163L increases radiation sensitivity in breast cancer cells
Gómez‐Millán, J., Goldblatt, E. M., Gryaznov, S. M., Mendonca, M. S., & Herbert, B. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.09.038 · Cited by 74
Antiadhesive Effects of GRN163L—An Oligonucleotide N3′→P5′ Thio-Phosphoramidate Targeting Telomerase
Jackson, S. R., Zhu, C.-H., Paulson, V., Watkins, L., Dikmen, Z. G., Gryaznov, S. M., Wright, W. E., & Shay, J. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2306 · Cited by 72
Idiopathic Pulmonary Fibrosis — New Insights
Verma, S., & Slutsky, A. S. (2007) · New England Journal of Medicine · doi:10.1056/nejmcibr070490 · Cited by 70
Telomeres and telomerase as targets for cancer therapy
Zimmermann, S., & Martens, U. M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6481-8 · Cited by 63
Human Is a Unique Species among Primates in Terms of Telomere Length
Kakuo, S., Asaoka, K., & Ide, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1385 · Cited by 62
Generation of Telomeric G Strand Overhangs Involves Both G and C Strand Cleavage
Jacob, N. K., Kirk, K. E., & Price, C. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00131-x · Cited by 59
Frequency of telomerase-specific CD8+ T lymphocytes in patients with cancer
Filaci, G., Fravega, M., Setti, M., Traverso, P., Millo, E., Fenoglio, D., Negrini, S. M., Ferrera, F., Romagnoli, A., Basso, M., et al. (2005) · Blood · doi:10.1182/blood-2005-01-0258 · Cited by 57
Antitumor effects of specific telomerase inhibitor GRN163 in human glioblastoma xenografts
Ozawa, T., Gryaznov, S. M., Hu, L. J., Pongracz, K., Santos, R. A., Bollen, A. W., Lamborn, K. R., & Deen, D. F. (2004) · Neuro-Oncology · doi:10.1215/s1152851704000055 · Cited by 56
Telomere dynamics in human cells
Baird, D. M. (2007) · Biochimie · doi:10.1016/j.biochi.2007.08.003 · Cited by 55
Interaction of Human Telomerase with Its Primer Substrate
Wallweber, G. J., Gryaznov, S. M., Pongracz, K., & Pruzan, R. (2002) · Biochemistry · doi:10.1021/bi026914a · Cited by 55
Association between telomere length and VH gene mutation status in chronic lymphocytic leukaemia: clinical and biological implications
Hultdin, M., Rosenquist, R., Thunberg, U., Tobin, G., Norrback, K.-F., Johnson, A., Sundström, C., & Roos, G. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600763 · Cited by 55
A Phase I Study of the Optimized Cryptic Peptide TERT572Y in Patients with Advanced Malignancies
Mavroudis, D., Bolonakis, I., Cornet, S., Myllaki, G., Kanellou, P., Kotsakis, A. P., Galanis, A., Nikoloudi, I., Spyropoulou, M., Menez, J., et al. (2006) · Oncology · doi:10.1159/000096252 · Cited by 55
Telomerase Activity in Bovine Embryos During Early Development1
Xu, J., & Yang, X. (2000) · Biology of Reproduction · doi:10.1095/biolreprod63.4.1124 · Cited by 54
Inhibition of telomerase by BIBR 1532 and related analogues
Barma, D. K., Elayadi, A. N., Falck, J. R., & Corey, D. R. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00101-x · Cited by 52
Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse
Khoo, C. M., Carrasco, D. R., Bosenberg, M. W., Paik, J.-H., & DePinho, R. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700093104 · Cited by 52
Dyskeratosis Congenita: A Disorder of Defective Telomere Maintenance?
Walne, A. J., Marrone, A., & Dokal, I. S. (2005) · International Journal of Hematology · doi:10.1532/ijh97.05067 · Cited by 51
Telomerase Therapeutics for Degenerative Diseases
Harley, C. B. (2005) · Current Molecular Medicine · doi:10.2174/1566524053586671 · Cited by 51
Self-citation
Early hematopoietic reconstitution after clinical stem cell transplantation: evidence for stochastic stem cell behavior and limited acceleration in telomere loss
Thornley, I., Sutherland, R., Wynn, R. F., Nayar, R., Sung, L., Corpus, G., Kiss, T. L., Lipton, J. H., Doyle, J., Saunders, F., et al. (2002) · Blood · doi:10.1182/blood.v99.7.2387 · Cited by 51
Increased Safety with Preserved Antitumoral Efficacy on Hepatocellular Carcinoma with Dual-Regulated Oncolytic Adenovirus
Zhang, Q., Chen, G., Peng, L., Wang, X., Yang, Y., Liu, C., Shi, W., Su, C., Wu, H., Liu, X., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1491 · Cited by 48
Drug Insight: cancer cell immortality—telomerase as a target for novel cancer gene therapies
Keith, W. N., Bilsland, A. E., Hardie, M., & Evans, T. J. (2004) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0044 · Cited by 44
Telomere dynamics in childhood leukemia and solid tumors: a follow-up study
Franco, S., Ozkaynak, M. F., Sandoval, C., Tugal, O., Jayabose, S., Engelhardt, M. M., & Moore, M. A. S. (2003) · Leukemia · doi:10.1038/sj.leu.2402815 · Cited by 43
Telomerase immunity from bench to bedside: round one
Cortez-Gonzalez, X., & Zanetti, M. (2007) · Journal of Translational Medicine · doi:10.1186/1479-5876-5-12 · Cited by 43
Assembly of Mutant-Template Telomerase RNA into Catalytically Active Telomerase Ribonucleoprotein That Can Act on Telomeres Is Required for Apoptosis and Cell Cycle Arrest in Human Cancer Cells
Goldkorn, A., & Blackburn, E. H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3782 · Cited by 42
The Role of Surgery in N2 Non–Small Cell Lung Cancer
DeCamp, M. M., Ashiku, S. K., & Thurer, R. L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-9013 · Cited by 42
Telomerase vaccination has no detectable effect on SCID-repopulating and colony-forming activities in the bone marrow of cancer patients
Danet-Desnoyers, G.-A., Luongo, J. L., Bonnet, D. A., Domchek, S. M., & Vonderheide, R. H. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2005.07.011 · Cited by 41
Telomerase targeted oligonucleotide thio‐phosphoramidates in T24‐luc bladder cancer cells
Dikmen, Z. G., Wright, W. E., Shay, J. W., & Gryaznov, S. M. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21635 · Cited by 40
Benefits of bad telomeres
Hanahan, D. (2000) · Nature · doi:10.1038/35020662 · Cited by 39
Short telomeres and high telomerase activity in T-cell prolymphocytic leukemia
Röth, A., Dürig, J., Himmelreich, H., Bug, S., Siebert, R., Dührsen, U., Lansdorp, P. M., & Baerlocher, G. M. (2007) · Leukemia · doi:10.1038/sj.leu.2404968 · Cited by 33
Marked telomere shortening in mobilized peripheral blood progenitor cells (PBPC) following two tightly spaced high-dose chemotherapy courses with G-CSF
Ricca, I., Compagno, M., Ladetto, M., Rocci, A., Dell'Aquila, M., Omedè, P., Marco, F. D., D’Antico, S., Caracciolo, D., Ferrero, D., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2403652 · Cited by 29
Optimization of the TRAP assay to evaluate specificity of telomerase inhibitors
Piotrowska, K., Kleideiter, E., Mürdter, T. E., Taetz, S., Baldes, C., Schaefer, U. F., Lehr, C., & Klotz, U. E. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700352 · Cited by 28
GV-1001, an injectable telomerase peptide vaccine for the treatment of solid cancers.
Nava-Parada, P., & Emens, L. A. (2007) · PubMed · Cited by 28
Magnetic resonance imaging in cardiology
Rademakers, F. E. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12440-3 · Cited by 24
Harnessing Telomerase in Cancer Therapeutics
Fakhoury, J. J., Nimmo, G. A. M., & Autexier, C. (2007) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152007781058622 · Cited by 24
Phase I study of transgenic B lymphocyte immunization (TLI) against telomerase in androgen-independent prostate cancer (PC)
Millard, F. E., Gerloni, M., Darrah, D. D., Farness, P., & Zanetti, M. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.90140.2519 · Cited by 9
Telomerase activity in human germline and embryonic tissues and cells
Wright, W. E., Piatyszek, M. A., Rainey, W. E., Byrd, W., & Shay, J. W. (1996) · Developmental Genetics · doi:10.1002/(sici)1520-6408(1996)18:2

Flagged first, then by citations

Research works printed but not linked: 1

Dikmen, Z. et al. In vivo inhibition of lung cancer by GRN163L: a novel human telomerase inhibitor. Cancer Res. 7866–7873 (2005). · DOI · Paper page

Sorted by citations

Principles of cancer therapy: oncogene and non-oncogene addiction
Luo, J., Solimini, N. L., & Elledge, S. J. (2009) · Cell · doi:10.1016/j.cell.2009.02.024 · Cited by 1,765
Nanomedicine Applications of Hybrid Nanomaterials Built from Metal–Ligand Coordination Bonds: Nanoscale Metal–Organic Frameworks and Nanoscale Coordination Polymers
He, C., Liu, D., & Lin, W. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00125 · Cited by 1,011
Untitled work
Wang (2012) · doi:10.1161/circresaha.111.261388 · Cited by 957
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
Totoki, Y., Tatsuno, K., Covington, K. R., Ueda, H., Creighton, C. J., Kato, M., Tsuji, S., Donehower, L. A., Slagle, B. L., Nakamura, H., et al. (2014) · Nature Genetics · doi:10.1038/ng.3126 · Cited by 781
Role of Telomeres and Telomerase in Aging and Cancer
Shay, J. W. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0062 · Cited by 668

See all 734

Authors: Harley, C. B.
Affiliations: Geron (United States) (US)
Corresponding author: Harley, Calvin B.
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2008-03
Volume: 8
Issue: 3
Pages: 167-179
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc2275
OpenAlex: W2078805336
Cited by: 728
References: 147
Citations by year: 2026: 11 · 2025: 22 · 2024: 26 · 2023: 39 · 2022: 20 · 2021: 29 · 2020: 38 · 2019: 39 · 2018: 27 · 2017: 38 · 2016: 48 · 2015: 58 · 2014: 48 · 2013: 51 · 2012: 53
FWCI: 6.57
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Keywords: telomerase, telomerase inhibitors, GRN163L, cancer therapeutics, cancer stem cells, telomere length, cell kinetics, anticancer drug development
MeSH terms: Antineoplastic Agents, Clinical Trials as Topic, Enzyme Inhibitors, Humans, Immunotherapy, Kinetics, Medical Oncology, Models, Biological, Neoplasms, Oligonucleotides, Oligopeptides, Gene Expression Regulation, Neoplastic, Telomerase, Cancer Vaccines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Telomerase and cancer therapeutics

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks